|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 367.85 INR | +1.35% |
|
-5.30% | -10.68% |
| 15/05 | Aarti Drugs March-quarter consol profit 552.6 million rupees | RE |
| 15/05 | Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
EPS & Dividend: Aarti Drugs Limited
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 2.5 | 1 | - | 1 | - | 4 | 5.4 | 7.3 |
| Rate of return | 0.36% | 0.23% | - | 0.23% | - | 1.09% | 1.47% | 1.98% |
| EPS 2 | 30.09 | 22.12 | 17.97 | 18.56 | 18.35 | 21.36 | 24.7 | 29.2 |
| Distribution rate | 8.31% | 4.52% | - | 5.39% | - | 20% | 21.9% | 25% |
| Reference price 2 | 694.80 | 429.00 | 337.80 | 433.85 | 339.80 | 367.85 | 367.85 | 367.85 |
| Nbr of stocks (in thousands) | 93,200 | 92,600 | 92,600 | 91,935 | 91,935 | 91,270 | - | - |
| Announcement Date | 15/05/21 | 09/05/22 | 29/04/23 | 03/05/24 | 06/05/25 | 15/05/26 | - | - |
1INR in Million2INR
Estimates
Past dividends: Aarti Drugs Limited
| 09/02/2026 | Ex-dividend date - 2 INR | 10:30 am |
Upcoming Events: Aarti Drugs Limited
| 18/05/2026 | Earnings presentation | 11:00 am |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.09% | 1.47% | 18.39x | 2.22x | - | |
| 0.68% | 0.75% | 29.49x | 17.6x | 10.7x | |
| 2.35% | 2.46% | 24.23x | 6.1x | 5.59x | |
| 3.26% | 3.44% | 25.6x | -1439.65x | 6.33x | |
| 3.11% | 3.18% | 17.06x | 6.38x | 4.28x | |
| 1.84% | 1.94% | 22.87x | 5.3x | 4.75x | |
| 3.03% | 3.17% | 20.47x | 6.15x | 5.52x | |
| 2.99% | 3.11% | 49.69x | 5.65x | 4.66x | |
| 3.73% | 3.64% | 13.55x | 5.87x | 4.96x | |
| 3.09% | 3.27% | 21.22x | 15.82x | 5.75x | |
| Average | 2.52% | 2.64% | 24.26x | -136.86x | 5.84x | |
| Weighted average by Cap. | 2.27% | 2.37% | 25.92x | -150.18x | 6.72x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition